Clinical Trials Logo
  1. Home
  2. Non-infectious Uveitis
  3. NCT00456482

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

Non-infectious Uveitis Clinical Trial

Official title:
A Multicenter, Randomized, Double-Masked, Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide Implant in Subjects With Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

Clinical Trial Summary

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00456482
Study type Interventional
Source Bausch & Lomb Incorporated
Contact
Status Terminated
Phase Phase 2/Phase 3
Start date May 2002
Completion date April 2006
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05928754 - Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS N/A
Terminated NCT00646425 - The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis Phase 2
Recruiting NCT00720928 - Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease Phase 4
Completed NCT04018599 - Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Phase 1
Terminated NCT02951975 - Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Active, not recruiting NCT03634475 - A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis Phase 1/Phase 2
Completed NCT04207983 - A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) Phase 2
Completed NCT02748512 - Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis Phase 3
Recruiting NCT02706704 - Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis Phase 2
Terminated NCT01032915 - Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Phase 3
Not yet recruiting NCT04105452 - Study to Evaluate PL8177 in Subjects With Non Infectious Uveitis (NIU) Phase 2
Terminated NCT01090310 - Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis Phase 3
Completed NCT01694186 - Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert Phase 3
Completed NCT03308045 - Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis Phase 1/Phase 2
Completed NCT00468871 - Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy Phase 2/Phase 3